Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

METAPROTERENOL: 34 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
34
Total FAERS Reports
4 (11.8%)
Deaths Reported
18
Hospitalizations
34
As Primary/Secondary Suspect
2
Life-Threatening
Approved Prior to Jan 1, 1982
FDA Approved
Discontinued
Status
Yes
Generic Available

Active Ingredient: METAPROTERENOL SULFATE · FDA Application: 015874 ·

First Report: 201506 · Latest Report: 201907

What Are the Most Common METAPROTERENOL Side Effects?

#1 Most Reported
Drug hypersensitivity
18 reports (52.9%)
#2 Most Reported
Malaise
11 reports (32.4%)
#3 Most Reported
Hypertension
11 reports (32.4%)

All METAPROTERENOL Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Drug hypersensitivity 18 52.9% 0 11
Dysstasia 11 32.4% 0 11
Haemoglobin decreased 11 32.4% 0 11
Hypertension 11 32.4% 0 11
Malaise 11 32.4% 0 11
Drug ineffective 5 14.7% 1 2
Product use in unapproved indication 5 14.7% 0 5

Who Reports METAPROTERENOL Side Effects? Age & Gender Data

Gender: 63.0% female, 37.0% male. Average age: 48.8 years. Most reports from: US. View detailed demographics →

Is METAPROTERENOL Getting Safer? Reports by Year

YearReportsDeathsHosp.
2015 1 0 0
2019 1 0 0

View full timeline →

What Is METAPROTERENOL Used For?

IndicationReports
Product used for unknown indication 18

Official FDA Label for METAPROTERENOL

Official prescribing information from the FDA-approved drug label.